David E Neal

发表

Longitudinal prostate-specific antigen reference ranges: Choosing the underlying model of age-related changes

Richard M Martin, Kate Tilling, Andrew J Simpkin, 2016, Statistical methods in medical research.

Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohorts.

Hans Garmo, Richard M Martin, Chris Metcalfe, 2010, European urology.

Multiple loci with different cancer specificities within the 8q24 gene desert.

John L Hopper, Honglin Song, Thibaud Koessler, 2008, Journal of the National Cancer Institute.

Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.

Peter Kraft, Todd L Edwards, Nazneen Rahman, 2016, Cancer discovery.

Upregulation and Nuclear Recruitment of HDAC1 in Hormone Refractory Prostate Cancer

Hing Y Leung, David E Neal, C. Robson, 2004, The Prostate.

Validating the use of Hospital Episode Statistics data and comparison of costing methodologies for economic evaluation: an end-of-life case study from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)

Richard M Martin, Freddie C Hamdy, Julia Verne, 2016, BMJ Open.

Circulating insulin-like growth factors and IGF-binding proteins in PSA-detected prostate cancer: the large case-control study ProtecT.

Jenny Donovan, Jeff M P Holly, Richard M Martin, 2012, Cancer research.

RAS pathways in prostate cancer - mediators of hormone resistance?

David E Neal, Hayley C Whitaker, 2010, Current cancer drug targets.

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study

Chris Metcalfe, Freddie C Hamdy, Jenny L Donovan, 2012, BMJ : British Medical Journal.

The transcriptional programme of the androgen receptor (AR) in prostate cancer

David E Neal, C. Massie, A. Lamb, 2014, BJU international.

RB1 methylation by SMYD2 enhances cell cycle progression through an increase of RB1 phosphorylation.

Yusuke Nakamura, Ryuji Hamamoto, Gouji Toyokawa, 2012, Neoplasia.

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

Peter Kraft, Jenny Donovan, Anssi Auvinen, 2014, Nature Genetics.

Comparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis

Julian P T Higgins, Yinghui Wei, Rebecca M Turner, 2014, BMJ Open.

A germline variant in the TP53 polyadenylation signal confers cancer susceptibility

Kari Stefansson, Brian T Helfand, Torben Hansen, 2011, Nature Genetics.

A new look towards BAC-based array CGH through a comprehensive comparison with oligo-based array CGH

Olivier Poch, Nicolas Wicker, Maija Wolf, 2007, BMC Genomics.

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

Peter Kraft, Anssi Auvinen, Henrik Gronberg, 2013, Nature Genetics.

Corrigendum: Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells.

Carlos Caldas, Fengtang Yang, Rosalind Eeles, 2016, Genome research.

Screening for prostate cancer remains controversial

Richard M Martin, Freddie C Hamdy, Jenny L Donovan, 2009, The Lancet.

Investigating the prostate specific antigen, body mass index and age relationship: is an age–BMI-adjusted PSA model clinically useful?

Jenny Donovan, Sean Harrison, Richard M Martin, 2016, Cancer Causes & Control.

Analysis of the Genetic Phylogeny of Multifocal Prostate Cancer Identifies Multiple Independent Clonal Expansions in Neoplastic and Morphologically Normal Prostate Tissue

Andrew Menzies, Keiran Raine, Rosalind Eeles, 2015, Nature Genetics.

A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.

Suzanne Chambers, Peter Kraft, Anssi Auvinen, 2013, Human molecular genetics.

Tip60 and Histone Deacetylase 1 Regulate Androgen Receptor Activity through Changes to the Acetylation Status of the Receptor*

David E Neal, D. Neal, C. Robson, 2002, The Journal of Biological Chemistry.

Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells

Carlos Caldas, Fengtang Yang, Rosalind Eeles, 2015, Genome research.

Alcohol consumption and PSA-detected prostate cancer risk—A case-control nested in the ProtecT study

Sarah J Lewis, Freddie C Hamdy, Jenny L Donovan, 2012, International journal of cancer.

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

Nawaid Usmani, Suzanne Chambers, Martin Eklund, 2018, Nature Communications.

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.

David Gillatt, Richard M Martin, John Staffurth, 2017, The New England journal of medicine.

Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study.

Igor Jurisica, Mark J Dunning, Emilie Lalonde, 2014, The Lancet. Oncology.

A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer

Kari Stefansson, Brian T Helfand, Gudmar Thorleifsson, 2012, Nature Genetics.

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study

Suzanne Chambers, Peter Kraft, Henrik Gronberg, 2011, Nature Genetics.